Virax Biolabs Group (NASDAQ:VRAX) Stock Price & Analysis

–

USD

–(–)

Open

$2.95

Prev. Close

$2.85

High

$3.12

Low

$2.84

Company Profile

Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. The company is developing T cell-based test technologies intended to support an immunology profiling platform, with potential applications in post-acute infection syndromes, including Long COVID, and other chronic conditions linked to immune dysregulation.

CEOJames Foster

SectorHealthcare

IndustryBiotechnology

Employees26

IPO DateJul 21, 2022

ExchangeNASDAQ

Exchange NameNASDAQ

CurrencyUSD

Headquarters & Contact

AddressBioCity Glasgow

City / State / ZIPLanarkshire, SC, ML1 5UH

CountryUnited Kingdom

Phone44 20 7788 7414

Websitehttps://viraxbiolabs.com

Virax Biolabs Group Limited

Company Profile

Recently from Cashu